Literature DB >> 22082280

Effects of co-existing α-thalassaemia in sickle cell disease on hydroxycarbamide therapy and circulating nucleic acids.

Nisha Vasavda, Claire Woodley, Marlene Allman, Emma Drašar, Moji Awogbade, Jo Howard, Swee L Thein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22082280     DOI： 10.1111/j.1365-2141.2011.08937.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  4 in total

1.  Alpha-thalassaemia and response to hydroxyurea in sickle cell anaemia.

Authors:  Deepika S Darbari; Mehdi Nouraie; James G Taylor; Carlo Brugnara; Oswaldo Castro; Samir K Ballas
Journal:  Eur J Haematol       Date:  2014-01-30       Impact factor: 2.997

2.  Increased circulating fibrocytes are associated with higher reticulocyte percent in children with sickle cell anemia.

Authors:  Matthew S Karafin; Shibani Dogra; Mark Rodeghier; Marie Burdick; Borna Mehrad; C Edward Rose; Robert M Strieter; Michael R DeBaun; Robert C Strunk; Joshua J Field
Journal:  Pediatr Pulmonol       Date:  2015-06-30

3.  The Effect of Hydroxyurea Therapy in Bahraini Sickle Cell Disease Patients.

Authors:  Durjoy K Shome; Abdulla Al Ajmi; Ameera A Radhi; Eman J Mansoor; Kameela S Majed
Journal:  Indian J Hematol Blood Transfus       Date:  2015-03-18       Impact factor: 0.900

4.  Diagnosis of Sickle Cell Disease and HBB Haplotyping in the Era of Personalized Medicine: Role of Next Generation Sequencing.

Authors:  Adekunle Adekile; Nagihan Akbulut-Jeradi; Rasha Al Khaldi; Maria Jinky Fernandez; Jalaja Sukumaran
Journal:  J Pers Med       Date:  2021-05-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.